Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PEP news


From To
HIV Post-Exposure Prophylaxis Often Prescribed for Anxiety, not Need

A retrospective review of HIV-1 post-exposure prophylaxis (PEP) finds it is often prescribed in response to patients' emotional stress rather than according to treatment guidelines.

09 November 2018
MD Magazine
New York City's Hotline for HIV Exposure a Success, Study Finds

Post-exposure prophylaxis (PEP) is a proven way to prevent HIV transmission after a possible exposure. Though access to PEP has been spotty, a dial-in hotline program in New York City has helped qualified patients access PEP at their local pharmacies, raising the possibility that remote screening methods could be an important way to bolster PEP use.

23 October 2018
The Body Pro
Over 2,000 people in British Columbia are now prescribed on new life-saving HIV prevention drug

Strong numbers on the uptake of a new provincial government-funded drug program that significantly reduces the likelihood of HIV infection could have a major impact on BC’s growth rate of new cases of HIV.

30 June 2018
Daily Hive
New Zealand sees drop in people diagnosed with HIV

The number of people diagnosed with HIV in New Zealand has significantly dropped, according to the AIDS Epidemiology Group of Otago University. It has been the first time the number has decreased since 2011. Last year, 197 people were diagnosed, a drop of 46 compared to 2016 when 243 people were diagnosed with HIV. Dr Sue McAllister said despite the drop being encouraging, it was too early to determine whether the decline would be maintained.

20 June 2018
1 News Now
Study finds high burden of psychosocial issues among PEP users

74% had at least one psychosocial issue, including depression and/or problematic drug or alcohol use. Furthermore, nearly half of participants had more than one issue.

15 June 2018
Activists Demand Gilead Rescind nPEP Patient Access Program's Once-Per-Lifetime Use Limit

Gilead Sciences is coming under fire from HIV/AIDS activist groups for a recent change to its patient assistance program (PAP), which has imposed a once-per-lifetime limit on access to Truvada (tenofovir/FTC) as part of non-occupational post-exposure prophylaxis (nPEP). While the company will undertake "hardship reviews" for subsequent prescriptions, the activists say the process is unclear and will create a significant barrier to access, especially since nPEP should be started within 72 hours of possible exposure to HIV.

02 February 2018
The Body
A gay man’s first experience of using PEP

In recent months I experienced something I never thought I’d have to deal with when I faced the possibility that I might have contracted HIV.

30 January 2018
London doctors on verge of defeating HIV thanks to new programme

London doctors believe they could be on course to defeat HIV after a dramatic fall in the number of new infections, the Standard can reveal. An early intervention programme imported from San Francisco has seen a 42 per cent reduction in new cases of HIV at 56 Dean Street in Soho, the biggest sexual health clinic in Europe.

11 January 2017
London Evening Standard
Statement on the provision of PrEP and PEP

The Association of Directors of Public Health is calling for NHS England to commission a national programme for PrEP and for their commissioning of PEP to include the open access sexual health services commissioned by local authorities... Correspondence from NHS England to local authority commissioners makes it clear that they will not reimburse PEP provided by local authorities' sexual health services.

30 March 2016
Association of Directors of Public Health
People Are So Desperate For The Drug That Blocks HIV They're “Cheating” The NHS

It’s called “clinic hopping” and involves lying to doctors to get the drug Truvada. Those involved spoke to BuzzFeed News about the lengths they’ll go to for PrEP – and why.

04 February 2016
BuzzFeed News
← First12345Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.